ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $829,789 | +77.6% | 180,389 | +149.4% | 0.02% | +46.2% |
| Q2 2023 | $467,245 | -86.9% | 72,329 | -84.7% | 0.01% | -88.1% |
| Q1 2023 | $3,575,845 | +136.6% | 474,250 | +217.9% | 0.11% | +137.0% |
| Q4 2022 | $1,511,385 | -62.2% | 149,199 | -63.1% | 0.05% | -70.9% |
| Q3 2022 | $3,997,000 | +492.1% | 404,171 | +537.1% | 0.16% | +485.2% |
| Q2 2022 | $675,000 | +83.9% | 63,439 | +146.6% | 0.03% | +68.8% |
| Q4 2021 | $367,000 | – | 25,727 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |